Concepedia
Statistics
Publications
7
Citations
558
H-Index
Active since
1998
Affiliations
Novartis (Switzerland)(Current)
Idera Pharmaceuticals (United States)
Robert O. Sayers is an author at Novartis (Switzerland) specializing in apoptosis, life sciences, and pharmacology.
Publications per year
1998–2020
In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
Anu Srinivasan, Kevin A. Roth, Robert O. Sayers et al. · Cell Death and Differentiation · 1998 · 370 citations
Life Sciences, Neurobiology, Neuroscience +13
First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease
Steven D. Linton, Teresa Aja, Robert A. Armstrong et al. · Journal of Medicinal Chemistry · 2005 · 106 citations
Life Sciences, Pharmacokinetics, Pharmacology +14
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke
Steven D. Linton, Teresa Aja, Peter R. Allegrini et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 21 citations · Full text
Medicine, Neuroscience, Pharmacology +11
Long‐term protection of brain tissue from cerebral ischemia by peripherally administered peptidomimetic caspase inhibitors
Thomas L. Deckwerth, Lisa M. Adams, Peter R. Allegrini et al. · Drug Development Research · 2001 · 19 citations
Life Sciences, Neuroscience, Pharmacology +13
Structure–Activity relationships within a series of caspase inhibitors: effect of leaving group modifications
Brett R. Ullman, Teresa Aja, Thomas L. Deckwerth et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 18 citations · Full text
Pharmacy, Biochemistry, Medicinal Chemistry +13
1–5 of 7